Yaël Gernez, MD, PhD

Career

Education and training

Professional employment

Board certifications

Teaching, mentoring, and honors

Honors and awards

  • Advancing Diagnosis and Targeted Therapies for Genetic Interferonopathies, France–Stanford Center Collaborative Project, 2025–2026
  • 2024–2025 Pediatrics Fellowship Honor Roll for Teaching, Lucile Packard Children's Hospital, Stanford
  • 2022–2023 Pediatrics Fellowship Honor Roll for Teaching, Lucile Packard Children's Hospital, Stanford
  • 2020 IAPIDS Advanced Primary Immunodeficiency School, Lisbon, Portugal
  • Biodesign Faculty Fellowship, Stanford Byers Center for Biodesign, 2019–2020
  • AAAAI / Elliot and Roslyn Jaffe Third-Year Fellowship Food Allergy Research Award, Mount Sinai, 2017
  • Elizabeth Nash Memorial Fellowship, Cystic Fibrosis Research Inc., 2011–2012
  • SPARK / SPECTRUM Award, Stanford School of Medicine, 2010

Teaching

  • Medical conferences, School of Medicine of Marseilles, France — 2004–2005 and 2007

Mentoring

  • Erin Mitsunaga, master's student — Summer 2011
  • Marie Miglianico, French engineering student — Summer 2010
  • Tiffany Jauhari, undergraduate student, University of California, Santa Cruz — Summer 2009
  • Tammie Nguyen, MD student, University of California, San Diego — 2008–2009
  • Cameron McDonald-Hyman, MD-PhD student, University of Minnesota — Summer 2008

Professional organizations

I am a member of AAAAI, ACAAI, the Clinical Immunology Society, and EGID.

Oral presentations

  • Basophil activation is a reliable biomarker of allergic bronchopulmonary aspergillosis (ABPA) in CF: interim results of a longitudinal cohort study. R. B. Moss, J. Walters, C. E. Dunn, Z. A. Davies, C. Everson, R. Tirouvanziam, J. Tamaresis, L. A. Herzenberg, Y. Gernez.
  • Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis, could we identify it earlier? Y. Gernez, R. Tirouvanziam, C. E. Dunn, C. Everson, Z. A. Davies, L. A. Herzenberg, R. B. Moss. CFRI, 2011.
  • Basophil CD203c as a potential clinically relevant biomarker in Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis. Y. Gernez, R. Tirouvanziam, C. E. Dunn, C. Everson, Z. A. Davis, L. A. Herzenberg, R. B. Moss. European Cystic Fibrosis Conference, 2011.
  • Basophils and food allergy. Y. Gernez, R. Tirouvanziam, K. C. Nadeau, L. A. Herzenberg. Genetic Retreat, Stanford, 2010.
  • Disseminated Nontuberculous Mycobacterial infection in a Vietnamese Woman. Y. Gernez, K. Donis, N. Reshamwala, D. B. Lewis, K. C. Nadeau. PID Immunology, 2009.
  • A case of adult with PID. Y. Gernez, K. Donis, D. B. Lewis, K. C. Nadeau. Clinical Immunology Society conference, 2008.
  • Altered phosphorylated signal transducer and activator of transcription profile of CD4(+) CD161(+) T cells in asthma: modulation by allergic status and oral corticosteroids. Y. Gernez, R. Tirouvanziam, K. D. Nguyen, L. A. Herzenberg, A. M. Krensky, K. C. Nadeau. European Respiratory Conference and CPLF, 2007.

Patents

  • US Patent US20100112628 A1 — Methods and assays for detecting and quantifying pure subpopulations of white blood cells in immune system disorders, by Yaël Gernez, R. Tirouvanziam, K. Nadeau, and L. A. Herzenberg (2009). Stanford University Office of Technology Transfer, Stanford, CA.
  • US Patent US20100209950 A1 — Granulocyte-based methods for the detection and monitoring of immune system disorders, by Yaël Gernez, R. Tirouvanziam, K. Nadeau, and L. A. Herzenberg (2009). Granted as US Patent 9,891,213 B2 on February 13, 2018.
  • Disclosure of Patent — Granulocyte-based method for detecting Aspergillus species, by Yaël Gernez, R. Tirouvanziam, R. Moss, and L. A. Herzenberg (2011). A search on 2026-11-02 found no distinct published patent number for this disclosure, so it is listed without a patent link rather than linking it to a different patent.